Pat Cotroneo
2015
In 2015, Pat Cotroneo earned a total compensation of $2.8M as Chief Financial Officer at FibroGen, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $262,438 |
|---|---|
| Option Awards | $1,124,849 |
| Salary | $425,000 |
| Stock Awards | $951,137 |
| Other | $16,740 |
| Total | $2,780,164 |
Cotroneo received $1.1M in option awards, accounting for 40% of the total pay in 2015.
Cotroneo also received $262.4K in non-equity incentive plan, $425K in salary, $951.1K in stock awards and $16.7K in other compensation.
Rankings
In 2015, Pat Cotroneo's compensation ranked 3,442nd out of 13,638 executives tracked by ExecPay. In other words, Cotroneo earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,442 out of 13,638 | 75th |
Division Manufacturing | 1,250 out of 5,187 | 76th |
Major group Chemicals And Allied Products | 452 out of 1,857 | 76th |
Industry group Drugs | 361 out of 1,531 | 76th |
Industry Pharmaceutical Preparations | 287 out of 1,179 | 76th |
Source: SEC filing on April 24, 2017.
Cotroneo's colleagues
We found three more compensation records of executives who worked with Pat Cotroneo at FibroGen in 2015.